Campus Map/Tour Request Information Employment A-Z Index Directories
EDU Site
A Bold Heart Centennial Campaign

IRB: Reproductive Risk in Clinical Research

  • Homect_img
  • IRBct_img
  • Reproductive Risk in Clinical Research

Reproductive Risk in Clinical Research

No reference to contraception may be used in the informed consent form or any other materials shared with research participants. If reproductive risks have been identified in a proposed study, the following language is required in the informed consent form.

Avoidance of Pregnancy: The medicines and procedures used in this study may be unsafe for an unborn baby, an infant, sperm, and eggs. If you, a woman of child bearing potential, are a study/trial participant, you must agree to avoid pregnancy during your participation in this study and for ____________ months after the completion of the study (include protocol time frame as appropriate); if you, as a participant are a man, you must agree to not conceive a child during your participation in this study and for ____________ months after the completion of the study (include protocol timeframe as appropriate). If you do become pregnant during the study or if you father a child during the study, you should immediately notify Dr. ____________ (name of contact) at _____________ (contact information). In addition, if you are already pregnant or are breast feeding, you cannot participate in this study.

 


    For IRB or IRBNet questions, please contact irbhelp@marywood.edu.
    For web content editor questions, please contact cloftus@marywood.edu.
    Keith J. O'Neill Center for Healthy Families, Room 208 | 570-348-6211, x.2233